|
Mar 26
|
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
|
|
Mar 26
|
32 Countries with the Highest Rates of Diabetes
|
|
Mar 25
|
Why the Market Dipped But Novo Nordisk (NVO) Gained Today
|
|
Mar 25
|
Novo Nordisk strikes €1bn deal to expand into heart disease treatments
|
|
Mar 25
|
Tesla, Lucid, Novo Nordisk: Trending tickers
|
|
Mar 25
|
Novo Nordisk Buys Heart Disease Biotech for Up to $1.1 Billion
|
|
Mar 25
|
Uncovering Hidden Gems: 1 AI-Powered Healthcare Stock Set to Dominate the Market
|
|
Mar 25
|
UPDATE 2-Novo ready to seek German insurance coverage of Wegovy for heart use
|
|
Mar 25
|
Novo to acquire heart failure drug in $1B deal for Cardior
|
|
Mar 25
|
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
|
|
Mar 25
|
Novo Nordisk strikes deal worth up to $1.1 billion to expand cardio business
|
|
Mar 25
|
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
|
|
Mar 24
|
Is Viking Therapeutics Stock a Millionaire Maker?
|
|
Mar 22
|
Wegovy gains Medicare, Medicaid coverage for heart benefits
|
|
Mar 22
|
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
|
|
Mar 22
|
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
|
|
Mar 22
|
Ozempic maker Novo Nordisk has a new goal for its leadership team: Make sure no more than 10% of your staff are stressed
|
|
Mar 22
|
Did Eli Lilly Just One-Up Novo Nordisk?
|
|
Mar 22
|
UPDATE 2-Germany's health insurance could cover Wegovy for strokes, heart conditions, agency says
|
|
Mar 22
|
German public health body signals lenience in Wegovy insurance coverage
|